Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

3.3K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.3K
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

4.9K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ill Fate of Rectal Mucinous Adenocarcinoma: A Defect in Immunosurveillance or a Mucin Coating Effect?-The IMMUNOREACT 20 Study.

Cancers·2026
Same author

Integrative Bioinformatic Characterization of the HDAC6-Driven Cytoskeleton-Wnt Signaling Interface in Hepatocellular Carcinoma: Implications for Immune Modulation and Therapeutic Targeting.

International journal of molecular sciences·2026
Same author

Diagnostic Usefulness of LC-OCT in Mammary and Extramammary Paget Disease and Correlation With Vertical and Horizontal Histopathology: A Case Series.

The American Journal of dermatopathology·2026
Same author

Unveiling the molecular profile of adenosquamous gallbladder carcinoma: characterization of a Caucasian cohort.

Histopathology·2026
Same author

Perioperative Outcomes of No-Drain Strategy in Primary Repair of Perforated Peptic Ulcer: A Systematic Review and Meta-Analysis.

Medicina (Kaunas, Lithuania)·2026
Same author

Correction: Cazzato et al. Skin Mycetoma in an 11-Year-Old African Boy: Case Presentation with Emphasis on Histopathological Features and Differential Diagnosis. <i>Dermatopathology</i> 2021, <i>8</i>, 509-514.

Dermatopathology (Basel, Switzerland)·2026

Related Experiment Video

Updated: Aug 5, 2025

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
09:57

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

29.5K

Mast Cell Leukemia: An Update with a Practical Review.

Magda Zanelli1, Martina Quintini2, Salvatore Magnasco3

  • 1Pathology Unit, Azienda USL-IRCCS di Reggio Emilia, 42123 Reggio Emilia, Italy.

Cancers
|March 29, 2023
PubMed
Summary
This summary is machine-generated.

Mast cell leukemia (MCL) is a rare, aggressive blood cancer characterized by immature mast cells. This overview synthesizes current knowledge on MCL, covering its clinical features, diagnosis, and treatment for better understanding and management.

Keywords:
KIT mutationMCL-AHNMCL-AMNmast cell leukemiamidostaurinsystemic mastocytosis

More Related Videos

Assessment of the Metabolic Profile of Primary Leukemia Cells
06:21

Assessment of the Metabolic Profile of Primary Leukemia Cells

Published on: November 21, 2018

10.6K
Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

14.1K

Related Experiment Videos

Last Updated: Aug 5, 2025

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
09:57

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

29.5K
Assessment of the Metabolic Profile of Primary Leukemia Cells
06:21

Assessment of the Metabolic Profile of Primary Leukemia Cells

Published on: November 21, 2018

10.6K
Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

14.1K

Area of Science:

  • Hematology
  • Oncology
  • Pathology

Background:

  • Mast cell leukemia (MCL) is the leukemic manifestation of systemic mastocytosis (SM).
  • It is defined by ≥20% immature mast cells in bone marrow aspirates.
  • MCL can arise de novo or progress from prior SM, with acute and chronic forms identified.

Purpose of the Study:

  • To provide a comprehensive overview of mast cell leukemia (MCL).
  • To consolidate current knowledge on MCL's clinical, morphological, phenotypic, and molecular aspects.
  • To guide differential diagnosis, prognosis, and treatment strategies for this rare hematologic neoplasm.

Main Methods:

  • Literature review and synthesis of existing studies on MCL.
  • Analysis of clinical data, diagnostic criteria, and treatment outcomes.
  • Inclusion of a general overview of mastocytosis for context.

Main Results:

  • MCL presents as an aggressive acute form with organ damage or a chronic form with potential progression.
  • The 2022 International Consensus Classification (ICC) updated terminology for MCL subtypes.
  • Knowledge gaps exist due to limited large-scale studies, with much data from case reports and series.

Conclusions:

  • A comprehensive understanding of MCL is crucial for accurate diagnosis and management.
  • Further research is needed to address knowledge gaps, particularly from larger cohort studies.
  • This overview aims to consolidate current understanding and inform future clinical practice and research.